Elaine Campbell
A retired senior executive with over 30 years of experience in the pharmaceutical and chemical industry, Elaine has broad commercial experience in sales and marketing, including early and pre-launch product development, product launch, and life cycle management. Her experience includes Global and North American roles. Elaine was the president of AstraZeneca Canada from 2012 to 2015.
Dan Suesskind
Dan was the Global CFO of Teva Pharmaceuticals, a $45 billion market cap company, from 1987-2008. Among his achievements, Dan registered Teva on the NASDAQ, led multiple successful acquisitions, and raised over $6 billion in the U.S. During Dan’s tenure with Teva, sales rose from $28 million to $11 billion.
Mary Rotunno
Mary L. Rotunno, JD is General Counsel and Executive Leadership Team member at El Camino Health, a $1.2 billion revenue health care system in Silicon Valley, California. Before joining El Camino Health, Mary spent more than 11 years as Senior Counsel and Client Service Leader for Common Spirit Health, formerly Dignity Health. She has also held legal roles at Varian Medical Systems, Manatt, Phelps & Phillips, Golden Living, and Pillsbury Winthrop Shaw Pitman. Ms. Rotunno is on the Board of Directors of VistaGen Therapeutics and is Chair of the Board for Momentum for Health, the largest provider of behavioral health services in Santa Clara County, California.
Ron Stern
Ron has over 15 years’ experience working in Growth Equity and Venture Capital investing, predominantly with Israeli related companies. Ron was a seven-year partner with Shamrock (Disney) where he built the Israeli investing team and facilitated four IPOs of Shamrock’s portfolio companies. He later served as a scout for Kleiner Perkins and was a senior international advisor to the Pritzker Group. Ron’s operational experience includes serving as CFO of Adgorithms, an Israel-based AI marketing company, which Ron helped take public on the London Stock Exchange, raising over $40 million for the company and its shareholders.
Frances Kang
Frances Kang is a venture capital investor at Horizons Ventures. Since joining in 2012, she has led many global technology investments and worked closely with entrepreneurs, building disruptive companies globally. Many of her early investments have become multi-billion-dollar businesses or public companies, such as WeFox, N26, Blockstream, Airwallex, Ajaib, Hippo, Doma, and Bakkt. She has been on the Boards of many highly dynamic, fast-growing technology companies. Frances graduated from Stanford Graduate School of Business.